Is the Mood Disorder Questionnaire an appropriate screening tool in detecting bipolar spectrum disorder among substance use populations?

Am J Drug Alcohol Abuse. 2011 Mar;37(2):79-81. doi: 10.3109/00952990.2010.538944. Epub 2010 Dec 8.

Abstract

Background: Bipolar spectrum disorder (BSD) has been shown to be difficult to assess in general and is further complicated by the presence of substance use disorder (SUD).

Objective: To review the specificity of the Mood Disorder Questionnaire (MDQ) in detecting BSD among substance abusers.

Method: A retrospective chart review was conducted using 183 SUD patients who were screened using the MDQ and later assessed by a psychiatrist specializing in BSD.

Results: Among SUD patients scoring positive results on the MDQ for the presence of BSD, the BSD diagnosis could only be confirmed in 23% of the sample by an expert psychiatrist.

Conclusions: The MDQ reports low specificity in detecting BSD among SUD populations.

Scientific significance: Physicians should question individuals on substance use behaviors if BSD is suspected due to high rates of comorbidity and diagnostic challenges.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bipolar Disorder / complications
  • Bipolar Disorder / diagnosis*
  • Bipolar Disorder / physiopathology
  • Diagnosis, Dual (Psychiatry)
  • Humans
  • Mass Screening
  • Psychometrics
  • Retrospective Studies
  • Sensitivity and Specificity
  • Substance-Related Disorders / complications*
  • Surveys and Questionnaires*